rabbit anti-thymocyte globulin (ATG)

DRUG3 trials

Sponsors

UNC Lineberger Comprehensive Cancer Center, Michael Pulsipher, Boston Children's Hospital

Conditions

Chronic Myeloproliferative DisordersLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesSevere Aplastic Anemia

Phase 1

Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

CompletedNCT00448357

UNC Lineberger Comprehensive Cancer CenterChronic Myeloproliferative Disorders, Leukemia, Lymphoma +2

Start: 2005-10-31End: 2015-11-30Updated: 2017-07-17

Phase 3

A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)

Active, not recruitingNCT05600426

Boston Children's HospitalSevere Aplastic Anemia

Start: 2023-01-25End: 2029-12-01Updated: 2026-07-30

Unknown Phase

Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia

CompletedNCT02845596

Michael PulsipherSevere Aplastic Anemia

Start: 2016-08-31End: 2023-07-19Target: 40Updated: 2025-05-11

Related Papers

Phase I/II Trial of Dose-Escalated Busulfan Delivered by Prolonged Continuous Infusion in Allogeneic Transplant Patients

Biology of Blood and Marrow Transplantation2015-07-227 citations